Literature DB >> 8564263

The effect of a synthetic 7-thiaprostaglandin E1 derivative, TEI-6122, on monocyte chemoattractant protein-1 induced chemotaxis in THP-1 cells.

H Tanaka1, T Minoshima, N Endo.   

Abstract

1 The ability of various prostaglandins (PGs) to inhibit monocyte chemotaxis induced by monocyte chemoattractant protein-1 (MCP-1) was investigated with a human monocytic leukaemia cell line, THP-1. Moreover, to investigate the mechanism of the inhibitory action of PGs the involvement of either intracellular adenosine 3': 5'-cyclic monosphosphate (cyclic AMP) accumulation or intracellular Ca2+ mobilization was studied. 2 TEI-6122, a synthetic 7-thia-PGE1 derivative, inhibited chemotaxis of THP-1 cells induced by MCP-1 with an IC50 of 1.5 pM. Its inhibitory activity was 1000 fold more than that of PGE1 and PGE2 (IC50 = 2.8 nM and 0.9 nM, respectively), which were more potent than other PGs such as PGA1, PGA2, PGF2 alpha and PGI2 (IC50 > or = 1 microM). 3 With respect to the effect on intracellular cyclic AMP accumulation in THP-1 cells, TEI-6122 was as potent as PGE1 and PGE2, which were approximately 100 to 1000 fold more potent than the other PGs such as PGA1, PGA2 and PGI2. The minimum concentration of TEI-6122 required to increase intracellular cyclic AMP accumulation in THP-1 cells was 1 nM. 4 TEI-6122 and PGE1 (4 microM) transiently increased intracellular calcium levels in THP-1 cells. When added prior to MCP-1, both PGs partially suppressed the increased in Ca2+ caused by this cytokine. There were no significant differences between the activity of TEI-6122 and PGE1 in either respect. 5 It is concluded that TEI-6122, a synthetic 7-thia-PGE1 derivative is a much more potent inhibitor of MCP-1-induced THP-1 cell chemotaxis than PGEI and PGE2 which are the best inhibitors among the natural PGs tested, while neither intracellular cyclic AMP accumulation nor effects on Ca2+ mobilization account for the extremely potent inhibitory activity of TEI-6122. Thus, either a novel PGE2 receptor (EPreceptor) or a novel intracellular signal transduction system may be involved in the extremely potent chemotaxis inhibitory activity of TEI-6122.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8564263      PMCID: PMC1908987          DOI: 10.1111/j.1476-5381.1995.tb15068.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype.

Authors:  Y Sugimoto; T Namba; A Honda; Y Hayashi; M Negishi; A Ichikawa; S Narumiya
Journal:  J Biol Chem       Date:  1992-04-05       Impact factor: 5.157

Review 2.  Thromboxane, prostaglandin and leukotriene receptors.

Authors:  P V Halushka; D E Mais; P R Mayeux; T A Morinelli
Journal:  Annu Rev Pharmacol Toxicol       Date:  1989       Impact factor: 13.820

3.  A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration.

Authors:  W Falk; R H Goodwin; E J Leonard
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

4.  Synthesis of 7-thiaprostaglandin E1 congeners: potent inhibitors of platelet aggregation.

Authors:  T Tanaka; N Okamura; K Bannai; A Hazato; S Sugiura; K Manabe; F Kamimoto; S Kurozumi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1985-06       Impact factor: 1.645

5.  Effect of prostaglandin E 1 on adjuvant arthritis.

Authors:  R B Zurier; F Quagliata
Journal:  Nature       Date:  1971-12-03       Impact factor: 49.962

6.  Monocyte chemoattractant protein-1 in human atheromatous plaques.

Authors:  N A Nelken; S R Coughlin; D Gordon; J N Wilcox
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

7.  Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists.

Authors:  A Severn; N T Rapson; C A Hunter; F Y Liew
Journal:  J Immunol       Date:  1992-06-01       Impact factor: 5.422

8.  Full active baculovirus-expressed human monocyte chemoattractant protein 1 with the intact N-terminus.

Authors:  K Ishii; S Yamagami; H Tanaka; M Motoki; Y Suwa; N Endo
Journal:  Biochem Biophys Res Commun       Date:  1995-01-26       Impact factor: 3.575

9.  Prostaglandin E1 inhibits effector T cell induction and tissue damage in experimental murine interstitial nephritis.

Authors:  C J Kelly; R B Zurier; K A Krakauer; N Blanchard; E G Neilson
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

10.  Anti-inflammatory effects of prostaglandin E1: in vivo modulation of the formyl peptide chemotactic receptor on the rat neutrophil.

Authors:  J C Fantone; W A Marasco; L J Elgas; P A Ward
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

View more
  1 in total

1.  Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity.

Authors:  Patrick Dorr; Mike Westby; Susan Dobbs; Paul Griffin; Becky Irvine; Malcolm Macartney; Julie Mori; Graham Rickett; Caroline Smith-Burchnell; Carolyn Napier; Rob Webster; Duncan Armour; David Price; Blanda Stammen; Anthony Wood; Manos Perros
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.